Anieta M Sieuwerts

Anieta M Sieuwerts

UNVERIFIED PROFILE

Are you Anieta M Sieuwerts?   Register this Author

Register author
Anieta M Sieuwerts

Anieta M Sieuwerts

Publications by authors named "Anieta M Sieuwerts"

Are you Anieta M Sieuwerts?   Register this Author

100Publications

3545Reads

25Profile Views

Generation of in situ sequencing based OncoMaps to spatially resolve gene expression profiles of diagnostic and prognostic markers in breast cancer.

EBioMedicine 2019 Oct 13;48:212-223. Epub 2019 Sep 13.

Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.09.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838368PMC
October 2019

Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer.

Int J Cancer 2019 08 27;145(4):1083-1089. Epub 2019 Feb 27.

Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32209DOI Listing
August 2019

Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer.

Cancers (Basel) 2019 Jul 27;11(8). Epub 2019 Jul 27.

Department of Pathology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11081062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721358PMC
July 2019

Proteome-wide onco-proteogenomic somatic variant identification in ER-positive breast cancer.

Clin Biochem 2019 Apr 23;66:63-75. Epub 2019 Jan 23.

Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Joseph and Wolf Lebovic Health Complex, 600 University Avenue, Toronto, ON M5G 1X5, Canada; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, 600 University Avenue, Toronto, ON M5G 1X5, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2019.01.005DOI Listing
April 2019

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2019 02;566(7742):E1

Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41586-019-0883-2
Publisher Site
http://dx.doi.org/10.1038/s41586-019-0883-2DOI Listing
February 2019

An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA.

J Mol Diagn 2019 Jan 6;21(1):123-137. Epub 2018 Oct 6.

Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Cancer Genomics Netherlands, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2018.08.010DOI Listing
January 2019

Dendritic Cells Actively Limit Interleukin-10 Production Under Inflammatory Conditions DC-SCRIPT and Dual-Specificity Phosphatase 4.

Front Immunol 2018 22;9:1420. Epub 2018 Jun 22.

Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.01420DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023963PMC
June 2018

Low Tumor Mitochondrial DNA Content Is Associated with Better Outcome in Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy.

Clin Cancer Res 2017 Aug 18;23(16):4735-4743. Epub 2017 Apr 18.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-0032DOI Listing
August 2017

Gene Expression Differences between Ductal Carcinoma in Situ with and without Progression to Invasive Breast Cancer.

Am J Pathol 2017 Jul;187(7):1648-1655

Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2017.03.012DOI Listing
July 2017

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor.

Neoplasia 2016 Nov 17;18(11):647-653. Epub 2016 Oct 17.

Erasmus MC Cancer Institute, Erasmus University Medical Center, Department of Medical Oncology and Cancer Genomics Netherlands, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2016.08.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071539PMC
November 2016

The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.

Sci Adv 2016 Oct 7;2(10):e1601737. Epub 2016 Oct 7.

Howard Hughes Medical Institute, University of Minnesota, Minneapolis, MN 55455, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.; Institute for Molecular Virology, University of Minnesota, Minneapolis, MN 55455, USA.; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/sciadv.1601737DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055383PMC
October 2016

APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma.

Clin Cancer Res 2016 Sep 25;22(18):4746-55. Epub 2016 Mar 25.

Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota. Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. Howard Hughes Medical Institute, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2016/03/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-2910DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026552PMC
September 2016

Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2016 06 2;534(7605):47-54. Epub 2016 May 2.

Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature17676DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910866PMC
June 2016

Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis.

Oncotarget 2016 May;7(20):29166-76

Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.8688DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045386PMC
May 2016

Shotgun proteomics on tissue specimens extracted with Acid guanidinium-thiocyanate-phenol-chloroform.

Methods Mol Biol 2015 ;1293:115-22

Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-2519-3_6DOI Listing
February 2016

The influence of tissue procurement procedures on RNA integrity, gene expression, and morphology in porcine and human liver tissue.

Biopreserv Biobank 2015 Jun;13(3):200-6

1Erasmus MC Tissuebank and Tissue Research Support Unit, Department of Pathology, Erasmus University Medical Centre, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2014.0076DOI Listing
June 2015

mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.

Mol Oncol 2015 Apr 21;9(4):920-32. Epub 2015 Jan 21.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528769PMC
April 2015

Integrative analysis of genomics and proteomics data on clinical breast cancer tissue specimens extracted with acid guanidinium thiocyanate-phenol-chloroform.

J Proteome Res 2015 Mar 2;14(3):1627-36. Epub 2015 Feb 2.

Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam , Be401, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jproteome.5b00046DOI Listing
March 2015

DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cells.

Breast Cancer Res Treat 2015 Feb 8;149(3):693-703. Epub 2015 Feb 8.

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3281-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326655PMC
February 2015

Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer.

Cancer Lett 2015 Jan 4;356(2 Pt B):872-9. Epub 2014 Nov 4.

Translational Cancer Research Unit, Oncology Center GZA Hospitals Sint-Augustinus, Oosterveldlaan 24, Antwerp 2610, Belgium; Department of Oncology, University of Antwerp, Universiteitsplein 1, Antwerp 2610, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2014.10.039DOI Listing
January 2015

Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers.

Horm Cancer 2014 Dec 15;5(6):405-13. Epub 2014 Aug 15.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Dr. Molewaterplein 50, 3015 GE, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12672-014-0196-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228172PMC
December 2014

Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.

J Natl Cancer Inst 2014 Feb 7;106(2):djt376. Epub 2014 Jan 7.

Affiliations of authors: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands (NQL, MPL, MS, RBHB, TDM, AMS, JWMM, JAF, AU); Department of Neurology (CS, TML) and Postgraduate School of Molecular Medicine (NQL, RBHB, TDM, AMS, JWMM, JAF, AU), Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Radiation Oncology (PNS) and Department of Laboratory Medicine (FCGJS), Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden (BKL); Department of Oncology/Pathology, Karolinska Institute, Stockholm, Sweden (BKL); Clinical Experimental Oncology Laboratory, National Cancer Centre Giovanni Paolo II, Bari, Italy (AM, AP); Translational Cancer Research Unit, Oncology Center, GZA Hospitals St-Augustinus, Antwerp, Belgium (LYD, SJVL); Netherlands Proteomics Centre, Utrecht, The Netherlands (NQL, AU); Cancer Genomics Centre, Utrecht, The Netherlands (MS, AMS, JWMM, JAF, AU); Center for Translational Molecular Medicine, Eindhoven, The Netherlands (RBHB, JAF, AU).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/early/2014/01/06/jnci
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/djt376
Publisher Site
http://dx.doi.org/10.1093/jnci/djt376DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952199PMC
February 2014

LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy.

Endocr Relat Cancer 2014 Feb 16;21(1):101-12. Epub 2014 Jan 16.

Departments of Radiation Oncology, Laboratory Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, PO Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
https://erc.bioscientifica.com/downloadpdf/journals/erc/21/1
Web Search
http://www.jbc.org/content/274/18/12692
Web Search
https://erc.bioscientifica.com/view/journals/erc/21/1/101.xm
Publisher Site
http://dx.doi.org/10.1530/ERC-13-0183DOI Listing
February 2014

Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.

Breast Cancer Res Treat 2013 Feb 22;138(1):47-57. Epub 2013 Jan 22.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2415-3DOI Listing
February 2013

The challenge of gene expression profiling in heterogeneous clinical samples.

Methods 2013 Jan 29;59(1):47-58. Epub 2012 May 29.

Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymeth.2012.05.005DOI Listing
January 2013

Multiplex molecular analysis of CTCs.

Recent Results Cancer Res 2012 ;195:125-40

Department of Translational Cancer Genomics and Proteomics, Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-3-642-28160-0_11
Publisher Site
http://dx.doi.org/10.1007/978-3-642-28160-0_11DOI Listing
July 2012

Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.

Breast Cancer Res Treat 2012 Jun 12;133(3):843-51. Epub 2011 Jul 12.

Department of Medical Oncology, Josephine Nefkens Institute and Daniel den Hoed Cancer Center, Erasmus MC, Building BE, Room 400, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1663-3DOI Listing
June 2012

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes.

Cancer Lett 2012 Jun 24;319(1):49-55. Epub 2011 Dec 24.

Erasmus MC, Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2011.12.031DOI Listing
June 2012

Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes.

Breast Cancer Res Treat 2012 Apr 26;132(2):439-48. Epub 2011 May 26.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1588-xDOI Listing
April 2012

Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women.

Mol Oncol 2011 Dec 16;5(6):504-16. Epub 2011 Sep 16.

Department of Medical Oncology, Josephine Nefkens Institute, Cancer Genomics Centre, Erasmus Medical Center, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2011.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528323PMC
December 2011

Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study.

Breast Cancer Res 2010 1;12(6):R103. Epub 2010 Dec 1.

Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Erasmus Medical Center, Rotterdam, GE, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2786DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046448PMC
September 2011

Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes.

Breast Cancer Res Treat 2011 Jul 15;128(1):23-30. Epub 2010 Jul 15.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus MC, DR, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-010-1026-5
Publisher Site
http://dx.doi.org/10.1007/s10549-010-1026-5DOI Listing
July 2011

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer.

Breast Cancer Res Treat 2011 May 19;127(1):43-51. Epub 2010 May 19.

Department of Medical Oncology, Erasmus Medical Center Rotterdam, Josephine Nefkens Institute and Cancer Genomics Centre, Dr. Molewaterplein 50, Be 4.02 (lab)/4.35b (office), PO Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-0940-xDOI Listing
May 2011

Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients.

Expert Rev Mol Diagn 2011 Apr;11(3):259-75

Daniel den Hoed Cancer Center, Laboratory of Clinical Tumor Immunology, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erm.11.11DOI Listing
April 2011

Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations.

Breast Cancer Res Treat 2010 Jul 18;122(1):125-33. Epub 2009 Sep 18.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-009-0545-4DOI Listing
July 2010

Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study.

Breast Cancer Res 2009 ;11(5):R75

Laboratory of Cancer Biology and Genetics, NCI, NIH, Room 5046, 37 Convent Drive, Bethesda, Maryland 20892-4264, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2412DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790856PMC
March 2010

Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response.

Endocr Relat Cancer 2010 Mar 18;17(1):215-30. Epub 2010 Feb 18.

Department of Pathology, Josephine Nefkens Institute, Erasmus MC - University Medical Center Rotterdam, Be432, Erasmus MC. PO Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1677/ERC-09-0062DOI Listing
March 2010

Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR.

Breast Cancer Res Treat 2009 Dec 30;118(3):455-68. Epub 2008 Dec 30.

Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Erasmus MC, Room BE-400, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10549-008-0290
Web Search
http://link.springer.com/10.1007/s10549-008-0290-0
Publisher Site
http://dx.doi.org/10.1007/s10549-008-0290-0DOI Listing
December 2009

Copy number alterations that predict metastatic capability of human breast cancer.

Cancer Res 2009 May 31;69(9):3795-801. Epub 2009 Mar 31.

Veridex LLC, a Johnson & Johnson Company, San Diego, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-4596DOI Listing
May 2009

Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.

J Clin Oncol 2009 Feb 15;27(4):542-9. Epub 2008 Dec 15.

Department of Pathology, Cancer Genomics Center, Josephine Nefkens Institute, Erasmus MC-University Medical Center Rotterdam, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.1462DOI Listing
February 2009

TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer.

Breast Cancer Res Treat 2009 Jan 26;113(2):253-60. Epub 2008 Feb 26.

Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Room Be 432, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-9934-3DOI Listing
January 2009

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

J Natl Cancer Inst 2009 Jan 30;101(1):61-6. Epub 2008 Dec 30.

Department of Medical Oncology, Josephine Nefkens Institute, Cancer Genomics Centre, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djn419DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639293PMC
January 2009

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.

Proc Natl Acad Sci U S A 2008 Sep 28;105(35):13021-6. Epub 2008 Aug 28.

Department of Medical Oncology, Erasmus Medical Center Rotterdam, Josephine Nefkens Institute, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0803304105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2529088PMC
September 2008

Subtypes of breast cancer show preferential site of relapse.

Cancer Res 2008 May;68(9):3108-14

Department of Medical Oncology, Erasmus MC, Josephine Nefkens Institute, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-5644DOI Listing
May 2008

Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer.

Endocr Relat Cancer 2008 Mar;15(1):101-11

Department of Pathology, Josephine Nefkens Institute, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1677/ERC-07-0080DOI Listing
March 2008

Circulating tumour cell detection on its way to routine diagnostic implementation?

Eur J Cancer 2007 Dec 30;43(18):2645-50. Epub 2007 Oct 30.

Department of Medical Oncology, Erasmus University Medical Center, Daniel den Hoed Cancer Clinic, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2007.09.016DOI Listing
December 2007